Home/Filings/4/0001601485-24-000053
4//SEC Filing

Connelly Robert 4

Accession 0001601485-24-000053

CIK 0001601485other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:14 PM ET

Size

5.7 KB

Accession

0001601485-24-000053

Insider Transaction Report

Form 4
Period: 2024-09-30
Connelly Robert
DirectorCEO, President and Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-09-30+91,60091,600 total
    Exercise: $5.03Exp: 2034-09-30Common Stock (91,600 underlying)
Footnotes (1)
  • [F1]Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Issuer

Elicio Therapeutics, Inc.

CIK 0001601485

Entity typeother

Related Parties

1
  • filerCIK 0001796436

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:14 PM ET
Size
5.7 KB